Proteasome-Mediated Proteolysis of SRSF5 Splicing Factor Intriguingly Co-occurs with SRSF5 mRNA Upregulation during Late Erythroid Differentiation

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Breig, Osman ^a,b   Baklouti, Faouzi ^a  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 1 LIKE KINASE; INTEIN; MESSENGER RNA PRECURSOR; SERINE; SPLICING FACTOR SRSF5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROID CELL; LATE ERYTHROID DIFFERENTIATION; MOLECULAR STABILITY; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA ANALYSIS; RNA SPLICING; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; ERYTHROID CELLS; ERYTHROID PRECURSOR CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE ALIGNMENT;

EID: 84874914211     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059137     Document Type: Article

References (67)

1. Manley JL, Krainer AR, (2010) A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes & development 24: 1073-1074.
2. Lin S, Fu XD, (2007) SR proteins and related factors in alternative splicing. Adv Exp Med Biol 623: 107-122.
3. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, et al. (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478: 64-69.
4. Zhang SJ, Rampal R, Manshouri T, Patel J, Mensah N, et al. (2012) Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood 119: 4480-4485.
5. Long JC, Caceres JF, (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417: 15-27.
6. Shepard PJ, Hertel KJ, (2009) The SR protein family. Genome Biol 10: 242.
7. Bourgeois CF, Popielarz M, Hildwein G, Stevenin J, (1999) Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5′ or 3′ splice site activation. Molecular and cellular biology 19: 7347-7356.
8. Zhu J, Mayeda A, Krainer AR, (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Molecular cell 8: 1351-1361.
9. Twyffels L, Gueydan C, Kruys V, (2011) Shuttling SR proteins: more than splicing factors. The FEBS journal 278: 3246-3255.
10. Zhong XY, Wang P, Han J, Rosenfeld MG, Fu XD, (2009) SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35: 1-10.
11. Soret J, Gabut M, Tazi J, (2006) SR proteins as potential targets for therapy. Prog Mol Subcell Biol 44: 65-87.
12. Stamm S, (2008) Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283: 1223-1227.
13. Blaustein M, Pelisch F, Srebrow A, (2007) Signals, pathways and splicing regulation. Int J Biochem Cell Biol 39: 2031-2048.
14. Ghosh G, Adams JA, (2011) Phosphorylation mechanism and structure of serine-arginine protein kinases. Febs J 278: 587-597.
15. Diamond RH, Du K, Lee VM, Mohn KL, Haber BA, et al. (1993) Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing. The Journal of biological chemistry 268: 15185-15192.
16. Han F, Gilbert JR, Harrison G, Adams CS, Freeman T, et al. (2007) Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation. Experimental cell research 313: 1518-1532.
17. Caputi M, Freund M, Kammler S, Asang C, Schaal H, (2004) A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. Journal of virology 78: 6517-6526.
18. Hallay H, Locker N, Ayadi L, Ropers D, Guittet E, et al. (2006) Biochemical and NMR study on the competition between proteins SC35, SRp40, and heterogeneous nuclear ribonucleoprotein A1 at the HIV-1 Tat exon 2 splicing site. The Journal of biological chemistry 281: 37159-37174.
19. Swanson CM, Sherer NM, Malim MH, (2010) SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. Journal of virology 84: 6748-6759.
20. Du K, Taub R, (1997) Alternative splicing and structure of the human and mouse SFRS5/HRS/SRp40 genes. Gene 204: 243-249.
21. Screaton GR, Caceres JF, Mayeda A, Bell MV, Plebanski M, et al. (1995) Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. The EMBO journal 14: 4336-4349.
22. Snow BE, Heng HH, Shi XM, Zhou Y, Du K, et al. (1997) Expression analysis and chromosomal assignment of the human SFRS5/SRp40 gene. Genomics 43: 165-170.
23. Friend C, Scher W, Holland JG, Sato T, (1971) Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proceedings of the National Academy of Sciences of the United States of America 68: 378-382.
24. Morinière M, Delhommeau F, Calender A, Ribeiro L, Delaunay J, et al. (2010) Nonsense-mediated mRNA decay (NMD) blockage promotes nonsense mRNA stabilization in protein 4.1R deficient cells carrying the 4.1R Coimbra variant of hereditary elliptocytosis. Blood Cells Mol Dis 45: 284-288.
25. England SJ, McGrath KE, Frame JM, Palis J, (2011) Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus. Blood 117: 2708-2717.
26. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proceedings of the National Academy of Sciences of the United States of America 96: 10403-10408.
27. Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, et al. (2000) The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. Journal of immunology 164: 6147-6157.
28. Patel NA, Chalfant CE, Watson JE, Wyatt JR, Dean NM, et al. (2001) Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells. J Biol Chem 276: 22648-22654.
29. Blaustein M, Pelisch F, Tanos T, Munoz MJ, Wengier D, et al. (2005) Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 12: 1037-1044.
30. Patel NA, Kaneko S, Apostolatos HS, Bae SS, Watson JE, et al. (2005) Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J Biol Chem 280: 14302-14309.
31. Breig O, Theoleyre O, Douablin A, Baklouti F, (2010) Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop. Oncogene 29: 2807-2816.
32. Jiang K, Patel NA, Watson JE, Apostolatos H, Kleiman E, et al. (2009) Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid. Endocrinology 150: 2087-2097.
33. Lee K, Du C, Horn M, Rabinow L, (1996) Activity and autophosphorylation of LAMMER protein kinases. The Journal of biological chemistry 271: 27299-27303.
34. Muraki M, Ohkawara B, Hosoya T, Onogi H, Koizumi J, et al. (2004) Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem 279: 24246-24254.
35. Baklouti F, Huang SC, Tang TK, Delaunay J, Marchesi VT, et al. (1996) Asynchronous regulation of splicing events within protein 4.1 pre-mRNA during erythroid differentiation. Blood 87: 3934-3941.
36. Deguillien M, Huang SC, Morinière M, Dreumont N, Benz EJ Jr, et al. (2001) Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood 98: 3809-3816.
37. Yang G, Huang SC, Wu JY, Benz EJ Jr, (2005) An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. Blood 105: 2146-2153.
38. Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Gervais-Bird J, et al. (2008) Multiple alternative splicing markers for ovarian cancer. Cancer research 68: 657-663.
39. Ponthier JL, Schluepen C, Chen W, Lersch RA, Gee SL, et al. (2006) Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. J Biol Chem 281: 12468-12474.
40. Yang G, Huang SC, Wu JY, Benz EJ Jr, (2008) Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation. Blood 111: 392-401.
41. Huang SC, Ou AC, Park J, Yu F, Yu B, et al. (2012) RBFOX2 Promotes Protein 4.1R Exon 16 Selection via U1 snRNP Recruitment. Molecular and cellular biology 32: 513-526.
42. Tazi J, Bakkour N, Stamm S, (2009) Alternative splicing and disease. Biochimica et biophysica acta 1792: 14-26.
43. Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, et al. (2008) E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell death and differentiation 15: 1815-1823.
44. McFarlane M, Graham SV, (2010) Human papillomavirus regulation of SR proteins. Biochemical Society transactions 38: 1116-1121.
45. Sureau A, Gattoni R, Dooghe Y, Stevenin J, Soret J, (2001) SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. Embo J 20: 1785-1796.
46. Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE, (2007) Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446: 926-929.
47. Palusa SG, Reddy AS, (2010) Extensive coupling of alternative splicing of pre-mRNAs of serine/arginine (SR) genes with nonsense-mediated decay. The New phytologist 185: 83-89.
48. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, et al. (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular cell 39: 925-938.
49. Baldin V, Militello M, Thomas Y, Doucet C, Fic W, et al. (2008) A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking. Molecular biology of the cell 19: 1706-1716.
50. Edmond V, Moysan E, Khochbin S, Matthias P, Brambilla C, et al. (2011) Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. The EMBO journal 30: 510-523.
51. Jung T, Catalgol B, Grune T, (2009) The proteasomal system. Molecular aspects of medicine 30: 191-296.
52. Moran-Crusio K, Reavie LB, Aifantis I, (2012) Regulation of hematopoietic stem cell fate by the ubiquitin proteasome system. Trends in immunology 33: 357-363.
53. Khandros E, Thom CS, D'Souza J, Weiss MJ, (2012) Integrated protein quality-control pathways regulate free alpha-globin in murine beta-thalassemia. Blood 119: 5265-5275.
54. de Thonel A, Vandekerckhove J, Lanneau D, Selvakumar S, Courtois G, et al. (2010) HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood 116: 85-96.
55. Lee TL, Shyu YC, Hsu PH, Chang CW, Wen SC, et al. (2010) JNK-mediated turnover and stabilization of the transcription factor p45/NF-E2 during differentiation of murine erythroleukemia cells. Proceedings of the National Academy of Sciences of the United States of America 107: 52-57.
56. Caceres JF, Krainer AR, (1993) Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. The EMBO journal 12: 4715-4726.
57. Chandler SD, Mayeda A, Yeakley JM, Krainer AR, Fu XD, (1997) RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins. Proceedings of the National Academy of Sciences of the United States of America 94: 3596-3601.
58. Zuo P, Manley JL, (1993) Functional domains of the human splicing factor ASF/SF2. The EMBO journal 12: 4727-4737.
59. Kohtz JD, Jamison SF, Will CL, Zuo P, Luhrmann R, et al. (1994) Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368: 119-124.
60. Wu JY, Tang H, Havlioglu N, (2003) Alternative pre-mRNA splicing and regulation of programmed cell death. Prog Mol Subcell Biol 31: 153-185.
61. Zhu J, Krainer AR, (2000) Pre-mRNA splicing in the absence of an SR protein RS domain. Genes & development 14: 3166-3178.
62. Kan JL, Green MR, (1999) Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes & development 13: 462-471.
63. Lin S, Xiao R, Sun P, Xu X, Fu XD, (2005) Dephosphorylation-dependent sorting of SR splicing factors during mRNP maturation. Molecular cell 20: 413-425.
64. Kloc M, Foreman V, Reddy SA, (2011) Binary function of mRNA. Biochimie 93: 1955-1961.
65. Blaybel R, Théoleyre O, Douablin A, Baklouti F, (2008) Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival. Cell Res 18: 834-845.
66. Théoleyre O, Deguillien M, Morinière M, Starck J, Moreau-Gachelin F, et al. (2004) Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells. Oncogene 23: 920-927.
67. Roth MB, Murphy C, Gall JG, (1990) A monoclonal antibody that recognizes a phosphorylated epitope stains lampbrush chromosome loops and small granules in the amphibian germinal vesicle. The Journal of cell biology 111: 2217-2223.